Fasenra subcutaneous injection 30mg pen (YJ code: 2290402G3023, standard: 30mg 1mL x 1 kit) is an AstraZeneca medication containing Benralizumab (genetical recombination). It is used as an add-on maintenance treatment for severe eosinophilic asthma in adults, and can also treat eosinophilic granulomatosis with polyangiitis (EGPA).
Fasenra subcutaneous injection 30mg pen
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →